NSE close · Thu, 1 OctNifty 5022,421.95▼ 0.88%Nifty Bank54,450.75▼ 0.33%Midcap 10058,732.00▼ 1.01%Smallcap 25017,589.05▼ 1.18%India VIX14.46▲ 7.19%IT28,304.70▲ 2.17%Auto25,384.95▼ 3.46%Pharma26,311.55▼ 0.48%FMCG43,789.85▼ 1.61%Metal12,460.70▼ 2.35%Realty835.00▼ 1.46%Energy36,388.15▼ 0.68%PSU Bank7,937.80▼ 0.98%Financials24,556.10▼ 0.38%Media1,546.30▼ 2.33%Defence9,142.55▼ 1.45%Durables35,927.80▼ 1.91%Biggest movesMONEYVIEW▲ 58.5%MOLBIO▲ 15.6%THOMASCOTT▲ 12.3%AUGMONT▲ 10.0%HEROMOTORS▲ 10.0%VIVIANA▲ 10.0%LOKESHMACH▲ 9.5%ANAWIL▼ 11.0%

Top stories

Zydus Lifesciences · 2 storiesClear filters

Developing 83 Picking up 1 Price moves 3 Following

Busiest tags today

AI79 Crude oil58 Bond yields55 Geopolitics51 Banks42 Global markets39 Trade and tariffs37 US jobs data36 Jobs and layoffs35 Inflation33 Autos30 US Treasuries27 RBI25 Wall Street24 Every tag in Market pulse →

Company · ZYDUSLIFE

Zydus Lifesciences▲ +50% net tone today

2 stories today · 14 since 25 Sept₹1,145.70 · −1.40% on Thu, 1 Oct · −2.9% in 5 days

Often with, this weekPharma and healthcare5 USFDA3 Market valuations2 Aegis Vopak Terminals1 Balrampur Chini Mills1

Open tag page →Clear ×

Stories per day

027 Sept

428 Sept

429 Sept

030 Sept

11 Oct

22 Oct

03 Oct

Expansion▲

New launches, chronic portfolio to maintain growth for Zydus Lifesciences

Domestic formulations, chronic therapies and US launches have supported Zydus Lifesciences’ growth and rally
Valuations now stand above…
Growth supports Zydus Lifesciences, though elevated valuations may limit further gains

Zydus Lifesciences Pharma and healthcare Market valuations1 source · 15h

Broker call●

Zydus Life, Sona Comstart Dr Lal Pathlabs: Top stocks to trade - Price targets, stop loss & more

Dr Lal PathLabs Zydus Lifesciences1 source · 21h

That’s everything for today